309 related articles for article (PubMed ID: 22457519)
21. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
22. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
24. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
Front Immunol; 2020; 11():304. PubMed ID: 32194557
[TBL] [Abstract][Full Text] [Related]
25. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism.
Plante K; Wang E; Partidos CD; Weger J; Gorchakov R; Tsetsarkin K; Borland EM; Powers AM; Seymour R; Stinchcomb DT; Osorio JE; Frolov I; Weaver SC
PLoS Pathog; 2011 Jul; 7(7):e1002142. PubMed ID: 21829348
[TBL] [Abstract][Full Text] [Related]
26. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
Chua CL; Sam IC; Merits A; Chan YF
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
[TBL] [Abstract][Full Text] [Related]
27. Genetic Characterization of Northwestern Colombian Chikungunya Virus Strains from the 2014-2015 Epidemic.
Rodas JD; Kautz T; Camacho E; Paternina L; Guzmán H; Díaz FJ; Blanco P; Tesh R; Weaver SC
Am J Trop Med Hyg; 2016 Sep; 95(3):639-46. PubMed ID: 27430542
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.
Muthumani K; Lankaraman KM; Laddy DJ; Sundaram SG; Chung CW; Sako E; Wu L; Khan A; Sardesai N; Kim JJ; Vijayachari P; Weiner DB
Vaccine; 2008 Sep; 26(40):5128-34. PubMed ID: 18471943
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
[TBL] [Abstract][Full Text] [Related]
30. Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.
Wang E; Kim DY; Weaver SC; Frolov I
J Virol; 2011 Sep; 85(17):9249-52. PubMed ID: 21697494
[TBL] [Abstract][Full Text] [Related]
31. Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.
van den Doel P; Volz A; Roose JM; Sewbalaksing VD; Pijlman GP; van Middelkoop I; Duiverman V; van de Wetering E; Sutter G; Osterhaus AD; Martina BE
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3101. PubMed ID: 25188230
[TBL] [Abstract][Full Text] [Related]
32. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
[TBL] [Abstract][Full Text] [Related]
33. Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.
Bao H; Ramanathan AA; Kawalakar O; Sundaram SG; Tingey C; Bian CB; Muruganandam N; Vijayachari P; Sardesai NY; Weiner DB; Ugen KE; Muthumani K
Viral Immunol; 2013 Feb; 26(1):75-83. PubMed ID: 23409931
[TBL] [Abstract][Full Text] [Related]
34. Development of Vaccines for Chikungunya Fever.
Erasmus JH; Rossi SL; Weaver SC
J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
[TBL] [Abstract][Full Text] [Related]
35. Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus.
Cao L; Wang W; Sun W; Zhang J; Han J; Xie C; Ha Z; Xie Y; Zhang H; Jin N; Lu H
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016401
[TBL] [Abstract][Full Text] [Related]
36. Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus.
Darwin JR; Kenney JL; Weaver SC
Am J Trop Med Hyg; 2011 Jun; 84(6):1012-5. PubMed ID: 21633043
[TBL] [Abstract][Full Text] [Related]
37. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
39. A chikungunya fever vaccine utilizing an insect-specific virus platform.
Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
[TBL] [Abstract][Full Text] [Related]
40. Chikungunya virus and prospects for a vaccine.
Weaver SC; Osorio JE; Livengood JA; Chen R; Stinchcomb DT
Expert Rev Vaccines; 2012 Sep; 11(9):1087-101. PubMed ID: 23151166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
